|
Prostate PSA Test - the Reasons
One of the most common types of cancer that affects males is prostate cancer. In the United States , actually , there is one case for every 6 men. The cancer grows gradually and is usually concentrated on the prostate gland. There are patients who do not show any signs because their tumor grows too gradually while others grow so rapidly that they have to be treated immediately .
The Importance Of Annual Prostate Cancer Screenings
When September rolls around, people often think about the beginning of school and fall, but a select few may remember that September is Prostate Cancer Awareness Month According to the American Cancer Society, prostate cancer affects one in six men, with skin cancer being the leading cause of cancer-related death
Enlarged Prostate Tests
Prostate enlargement, or benign prostatic hyperplasia, is a common diagnosis that affect many men over the age of forty years or older While it is not a common cause of prostate cancer, it can cause the bladder to shut down if it is not treated, as well as urinary tract infections, and a great deal of discomfort
|
|
 |
 |
|
Why You Should Consider a Prostate Cancer PSA Test TODAY.
Prostate Cancer kills if allowed to grow. If ever there was a good reason to have a simple blood test, this is it. The Prostate cancer PSA (Prostate Specific Antigen) test is one of the tests given to determine if cancer cells are present in an otherwise healthy prostate. It is a simple blood test to help doctors diagnose and identify the existence of prostate cancer.
The Importance Of Annual Prostate Cancer Screenings
When September rolls around, people often think about the beginning of school and fall, but a select few may remember that September is Prostate Cancer Awareness Month According to the American Cancer Society, prostate cancer affects one in six men, with skin cancer being the leading cause of cancer-related death
Comprehensive PSA Test for Most Prevalent Male Cancer
For decades the "gold standard" in testing for prostate cancer - the most prevalent and deadly male cancer - has been the Total PSA screening. Yet, simply measuring the amount of PSA in the bloodstream has its drawbacks. Researchers have discovered a new, more comprehensive way to measure PSA in the bloodstream that can lead to more accurate diagnosis. A newer and more accurate test measures the ratio between "free" PSA and total PSA in the bloodstream to determine how likely it is that a malignant prostate tumor is present.
|
 |
|
